Cholangiocellular Carcinoma

7 clinical trials · Condition

Record	Firm	Date
A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors (NCT02999672)	Hoffmann-La Roche	2016-12-23
Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors (NCT02156700)	University Hospital Dubrava	2013-09-01
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) (NCT01862315)	Memorial Sloan Kettering Cancer Center	2013-05-01
Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy (NCT01692704)	University of Zurich	2012-04-01
Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture (NCT01320241)	Southeast University, China	2008-11-01
Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. (NCT01073839)	University of Zurich	2008-08-01
Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers (NCT00832637)	New Mexico Cancer Research Alliance	2007-08-01

Every clearance here is in the API, with alerts when new ones post.